forked from website/openpower.foundation
				
			
			You cannot select more than 25 topics
			Topics must start with a letter or number, can include dashes ('-') and can be up to 35 characters long.
		
		
		
		
		
			
		
			
				
	
	
		
			31 lines
		
	
	
		
			1.5 KiB
		
	
	
	
		
			Markdown
		
	
			
		
		
	
	
			31 lines
		
	
	
		
			1.5 KiB
		
	
	
	
		
			Markdown
		
	
---
 | 
						|
title: Porting and Benchmarking of BWAKIT pipeline on Open POWER architecture
 | 
						|
link:
 | 
						|
tags:
 | 
						|
  - software
 | 
						|
  - hardware
 | 
						|
  - power8
 | 
						|
  - genomemapping
 | 
						|
date: 2017-09-20
 | 
						|
draft: false
 | 
						|
---
 | 
						|
 | 
						|
This paper describes how to port various pre-built application binaries used in BWAKIT into OpenPOWER architecture and
 | 
						|
execute the BWAKIT pipeline successfully.  
 | 
						|
 | 
						|
Next Generation Sequencing (NGS) technology produces large volume of genome data,
 | 
						|
which gets processed using various open source Bioinformatics tools.
 | 
						|
The configuration and compilation of some of the bioinformatics tools (e.g. BWAKIT, root) are challenging,
 | 
						|
requiring application porting for some architectures (e.g. IBM Power).
 | 
						|
Moreover, the application porting should not change the semantics of the program and output generated
 | 
						|
from different architectures should be similar across different architectures.
 | 
						|
Burrows-Wheeler Aligner (BWA) is the most popular genome mapping application used in BWAKIT toolset.
 | 
						|
The BWAKIT provides pre-compiled binaries for x86_64 architecture and end-to-end solution for genome mapping.
 | 
						|
This paper describes how to port various pre-built application binaries used in BWAKIT into OpenPOWER architecture and
 | 
						|
execute the BWAKIT pipeline successfully.
 | 
						|
In addition, it reports the validation of the output results on OpenPOWER to confirm the successful porting of BWAKIT.  
 | 
						|
 | 
						|
_Note: This paper is the result of collaboration within members of the Personalized Medicine Workgroup and Sidra medical and Research Center._
 | 
						|
 | 
						|
 |